E-Da Hospital

Futó vizsgálatok

• Toboroz

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· 3. fázis· Forrás

• Toboroz

  Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

  NCT07370207· 2. fázis· Forrás

• Toboroz

  Hybrid Stroke Rehab With Mirror Priming

  NCT07324278· Forrás

• Toboroz

  Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  NCT07100080· 2/3. fázis· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Forrás

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Forrás

• Toboroz

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· 3. fázis· Forrás

• Toboroz

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· 3. fázis· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· 3. fázis· Forrás

• Toboroz

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· 3. fázis· Forrás

• Fut, nem toboroz

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· 3. fázis· Forrás

• Toboroz

  Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)

  NCT06277037· Forrás

• Toboroz

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· 3. fázis· Forrás

• Meghívásos bevonás

  ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

  NCT06194799· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

  NCT06012435· 3. fázis· Forrás

• Fut, nem toboroz

  MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06132256· 2. fázis· Forrás

• Toboroz

  ACP-204 in Adults With Alzheimer's Disease Psychosis

  NCT06159673· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Forrás

• Fut, nem toboroz

  Finite Versus Continuous Nucleos(t)Ide Analogues for Chronic Hepatitis B

  NCT05793268· Forrás

• Toboroz

  Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration

  NCT05557487· Forrás

• Toboroz

  Formatting the Risk Prediction Models for Never-Smoking Lung Cancer

  NCT05572944· Forrás

• Fut, nem toboroz

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· 3. fázis· Forrás

• Fut, nem toboroz

  Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

  NCT05462717· 1. fázis· Forrás

• Meghívásos bevonás

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· 3. fázis· Forrás

• Fut, nem toboroz

  HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

  NCT05338970· 3. fázis· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

  NCT05186974· 2. fázis· Forrás

• Fut, nem toboroz

  Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

  NCT05215340· 3. fázis· Forrás

• Fut, nem toboroz

  A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

  NCT05091567· 3. fázis· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

  NCT04680052· 3. fázis· Forrás

• Fut, nem toboroz

  HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

  NCT04619004· 2. fázis· Forrás

• Fut, nem toboroz

  Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

  NCT04656652· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT04487080· 3. fázis· Forrás

• Fut, nem toboroz

  Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

  NCT04496882· 4. fázis· Forrás

• Fut, nem toboroz

  Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

  NCT04285086· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

  NCT04194944· 3. fázis· Forrás

• Fut, nem toboroz

  Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

  NCT03024684· 4. fázis· Forrás

• Fut, nem toboroz

  A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)

  NCT02411448· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák6 toboroz
• Alzheimer-kór2 toboroz
• Hepatitis B (krónikus)2 toboroz
• Szívelégtelenség2 toboroz
• Zsírmáj (MASLD/MASH)2 toboroz
• Crohn-betegség1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Stroke (szélütés)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Forrás

• Lezárult

  Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

  NCT05770895· 1. fázis· Forrás

• Lezárult

  A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

  NCT05717686· 1. fázis· Forrás

• Lezárult

  Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT05255991· 3. fázis· Forrás

• Lezárult

  An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

  NCT05275023· 2. fázis· Forrás

• Lezárult

  Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

  NCT05054725· 2. fázis· Forrás

• Lezárult

  A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

  NCT05123599· 1. fázis· Forrás

• Lezárult

  A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

  NCT04909034· Forrás

• Lezárult

  NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

  NCT04614441· Forrás

• Lezárult

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· 3. fázis· Forrás

• Lezárult

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· 3. fázis· Forrás

Vizsgálati helyszínek

• E-DA Hospital1 vizsgálat
• E-DA Hospital47 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Hepatitis B (krónikus)12 munka · 8 vizsgálat